CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Trans. Hemat. dnes, 10, 2004, No. 3, p. 112–113.
 
The succesfull treatment of follicular lymphoma relaps performed by 90Y Ibritumomab tiuxetan (Zevalin) 
Slabý J.1, Kozák T.1, Bělohlávek O.2, Lang O.3 

1Oddělení klinické hematologie, FNKV, Praha, 2PET centrum, Nemocnice Na Homolce, Praha, 3Oddělení nukleární medicíny, FNKV, Praha
 


Summary:

       Radioimmunotherapy represents the other step in specific anti-tumor therapy. 57-years old woman received Ytrium 90 ibritumomab tiuxetan (Zevalin) as a treatment of relaps of follicular lymphoma. Treatment was tolerated very well; it was followed by uncomplicated trombocytopenia (Gr. 3, WHO classification) andneutropenia (Gr. 2,WHOclassification).PET-CT evaluationperformed after finishing of treatment revealed achievement of complete remission.

        Key words: radioimmunotherapy, Ytrium 90 ibritumomab tiuxetan, follicular lymphoma
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER